Website of Radiopharm Theranostics

https://www.radiopharmtheranostics.com

Radiopharm Theranostics News

What does Radiopharm Theranostics do?

Radiopharm Theranostics (ASX:RAD) is a radiopharmaceutical company that develops and commercialises innovative diagnostic and therapeutic products for the treatment of cancer and other diseases. Radiopharm Theranostics’ operations are focused on the development of new radiopharmaceuticals, as well as the commercialisation of its existing products in Australia and other international markets. The company aims to develop and commercialise innovative radiopharmaceutical products for the treatment of cancer and other diseases.

Company Snapshot

Ownership

Public

Employees

Sector

Health Care

Head Office

Sydney, Australia

Year Founded

2021

What does Radiopharm Theranostics specialise in?

/Radiopharmaceuticals /Theranostic /Diagnostics /Biotech /Pharmaceutical /Health

What are the products and/or services of Radiopharm Theranostics?

Overview of Radiopharm Theranostics offerings

Nano-mAbs: an esteemed radiopharmaceutical and nuclear medicine specialist formerly associated with the University of Oxford, is a pioneering radiopharmaceutical platform.

Pivalate: derived from a short-chain carbohydrate. It exploits early stages of fatty acid oxidation and exhibits remarkable stability.

AVß6: a potent ligand targeting the cell surface protein avß6-integrin. It selectively accumulates in areas with heightened avß6-integrin levels.

DUNP19: designed to simultaneously address tumours and their surrounding tumour micro-environment cells, including stromal and immune cells.

PTPµ (PTPmu): a peptide molecule biomarker designed for the precise detection, imaging, and treatment of tumours.

Who is in the executive team of Radiopharm Theranostics?

Radiopharm Theranostics leadership team

Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD
Founder & Executive Chairman
Mr. Riccardo Canevari
MD, CEO & Director
Mr. Phillip Hains
CFO, Joint Company Secretary & Director
Dr. Thomas H. Tulip Ph.D.
Chief Business Officer
Dr. Dimitris Voliotis M.D.
Chief Medical Officer
Mr. Nathan Jong C.A.
Joint Company Secretary